GB202017985D0 - Methods for assessing vaginal microbiota community type - Google Patents

Methods for assessing vaginal microbiota community type

Info

Publication number
GB202017985D0
GB202017985D0 GBGB2017985.9A GB202017985A GB202017985D0 GB 202017985 D0 GB202017985 D0 GB 202017985D0 GB 202017985 A GB202017985 A GB 202017985A GB 202017985 D0 GB202017985 D0 GB 202017985D0
Authority
GB
United Kingdom
Prior art keywords
methods
vaginal microbiota
community type
microbiota community
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2017985.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB2017985.9A priority Critical patent/GB202017985D0/en
Publication of GB202017985D0 publication Critical patent/GB202017985D0/en
Priority to PCT/GB2021/052958 priority patent/WO2022101646A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2017985.9A 2020-11-16 2020-11-16 Methods for assessing vaginal microbiota community type Ceased GB202017985D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2017985.9A GB202017985D0 (en) 2020-11-16 2020-11-16 Methods for assessing vaginal microbiota community type
PCT/GB2021/052958 WO2022101646A1 (en) 2020-11-16 2021-11-16 Methods for assessing vaginal microbiota community type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2017985.9A GB202017985D0 (en) 2020-11-16 2020-11-16 Methods for assessing vaginal microbiota community type

Publications (1)

Publication Number Publication Date
GB202017985D0 true GB202017985D0 (en) 2020-12-30

Family

ID=74046639

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2017985.9A Ceased GB202017985D0 (en) 2020-11-16 2020-11-16 Methods for assessing vaginal microbiota community type

Country Status (2)

Country Link
GB (1) GB202017985D0 (en)
WO (1) WO2022101646A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3374795A (en) 1994-08-29 1996-03-22 Prizm Pharmaceuticals, Inc. Conjugates of vascular endothelial growth factor with targeted agents
WO2012087983A1 (en) * 2010-12-20 2012-06-28 The General Hospital Corporation Polycomb-associated non-coding rnas
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
JP2020074712A (en) * 2018-11-08 2020-05-21 国立大学法人 東京大学 Use of vaginal microbiota as ovarian cancer biomarker
GB201905861D0 (en) * 2019-04-26 2019-06-12 Ucl Business Plc Methods of detecting cancer

Also Published As

Publication number Publication date
WO2022101646A1 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
EP3906404A4 (en) Using image analysis for evaluating medical conditions
WO2013033396A3 (en) Fap-activated proteasome inhibitors for treating solid tumors
EP2997162A4 (en) Methods for diagnosing and treating inflammatory bowel disease
EP4010698C0 (en) Bodily fluid testing method
WO2017055611A3 (en) Methods of using smad7 antisense oligonucleotides based on biomarker expression
IL276969B2 (en) Stool collection method and sample preparation method for transplanting fecal microbiota
EP3285071A4 (en) Biomarker composition for diagnosing still's disease, diagnostic kit, and diagnostic method
GB201908591D0 (en) Methods for cancer diagnosis
EP3602041A4 (en) Methods for diagnosing and treating inflammatory bowel disease
EP3965638C0 (en) Vaginal speculum
GB201818183D0 (en) Vaginal speculum
WO2013156546A3 (en) Endoprosthesis leakage analysis
HUE061155T2 (en) Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant
EP3817771A4 (en) Compositions and methods for treating inflammatory bowel disease
EP4061373A4 (en) Methods for treating inflammatory bowel disease
IL286509A (en) Methods for obtaining induced smooth muscle cells
GB202108326D0 (en) High floworate formation tester
GB202017985D0 (en) Methods for assessing vaginal microbiota community type
EP3564388A4 (en) Method for diagnosing prostatic disease via bacterial metagenomic analysis
EP3928716A4 (en) Exfoliative cell collection device for uterus examination
WO2015125027A3 (en) Kit and method for detecting bladder cancer
EP4077710A4 (en) Methods and compositions for monitoring and diagnosing healthy and disease states
EP4043881A4 (en) Cancer test method
EP3821035A4 (en) Methods for analyzing cells
EP3977075C0 (en) Celiac disease diagnosis method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)